The Company of Biologists has announced a three-year Read & Publish Open Access agreement with the Bibsam Consortium which runs from January 1, 2022, to December 31, 2024.
Corresponding authors at participating institutions in Sweden can publish an uncapped number of research articles immediately Open Access (OA) in the Company of Biologists’ hybrid subscription journals (Development, Journal of Cell Science, and Journal of Experimental Biology) plus their fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC).
Researchers at participating institutions also benefit from unlimited access to hybrid subscription journals, including their full archives dating back to 1853. This partnership with the Bibsam Consortium is also the Company of Biologists’ first-ever consortium agreement in Scandinavia.
Click here to read the original press release.
